Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Ivaldi

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Human Immunology|June 3, 2004
Recognition of CMV pp65 protein antigen by human CD4 T-cell lines induced with an immunodominant peptide poolGiuseppina Li Pira, Laura Bottone, Federico Ivaldi, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|April 14, 2021
Different Susceptibility of T and B Cells to Cladribine Depends On Their Levels of Deoxycytidine Kinase Activity Linked to Activation StatusFederico Carlini, Federico Ivaldi, Francesca Gualandi, et al.
Immunology Letters|December 7, 2016
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanomaIlaria Gandoglia, Federico Ivaldi, Paolo Carrega, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|January 9, 2016
Immunologic and Pharmacologic Aspects in an Elderly Recipient of Liver Transplant With Pulmonary Aspergillosis and Multiple ComorbiditiesElda Righi, Federico Ivaldi, Alessia Carnelutti, et al.
Immunology Letters|June 10, 2008
Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptidesCristina Ulivieri, Alessandra Citro, Federico Ivaldi, et al.
Journal of Autoimmunity|May 10, 2016
Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosisAlice Laroni, Eric Armentani, Nicole Kerlero de Rosbo, et al.
Acta Neuropathologica|March 31, 2016
NG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activationGiovanni Ferrara, Mariella Errede, Francesco Girolamo, et al.
The Journal of Infection|February 12, 2022
Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort studyElda Righi, Massimo Mirandola, Fulvia Mazzaferri, et al.
Genes and Immunity|June 12, 2025
Butyrate enhances CD56<sup>bright</sup> NK cell-driven killing of activated T cells and modulates NK cell chromatin accessibilityFederico Carlini, Margherita Squillario, Valentina Casella, et al.
CNS Drugs|December 11, 2021
Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational StudySerena Palmeri, Marta Ponzano, Federico Ivaldi, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Human Immunology|June 3, 2004
Recognition of CMV pp65 protein antigen by human CD4 T-cell lines induced with an immunodominant peptide poolGiuseppina Li Pira, Laura Bottone, Federico Ivaldi, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|April 14, 2021
Different Susceptibility of T and B Cells to Cladribine Depends On Their Levels of Deoxycytidine Kinase Activity Linked to Activation StatusFederico Carlini, Federico Ivaldi, Francesca Gualandi, et al.
Immunology Letters|December 7, 2016
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanomaIlaria Gandoglia, Federico Ivaldi, Paolo Carrega, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|January 9, 2016
Immunologic and Pharmacologic Aspects in an Elderly Recipient of Liver Transplant With Pulmonary Aspergillosis and Multiple ComorbiditiesElda Righi, Federico Ivaldi, Alessia Carnelutti, et al.
Immunology Letters|June 10, 2008
Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptidesCristina Ulivieri, Alessandra Citro, Federico Ivaldi, et al.
Journal of Autoimmunity|May 10, 2016
Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosisAlice Laroni, Eric Armentani, Nicole Kerlero de Rosbo, et al.
Acta Neuropathologica|March 31, 2016
NG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activationGiovanni Ferrara, Mariella Errede, Francesco Girolamo, et al.
The Journal of Infection|February 12, 2022
Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort studyElda Righi, Massimo Mirandola, Fulvia Mazzaferri, et al.
Genes and Immunity|June 12, 2025
Butyrate enhances CD56<sup>bright</sup> NK cell-driven killing of activated T cells and modulates NK cell chromatin accessibilityFederico Carlini, Margherita Squillario, Valentina Casella, et al.
CNS Drugs|December 11, 2021
Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational StudySerena Palmeri, Marta Ponzano, Federico Ivaldi, et al.
Pageof 5